Aehr Test SystemsAEHR
AEHR logo
Fair Value
US$130
Share price14 Aug
US$80.8137.8% undervalued intrinsic discount
Loading
1Y223.89%
7D-20.56%

AI Data Center Demand And Silicon Photonics Will Support Long-Term Prospects Here

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
14 Aug 26
Views
19
Not Invested

Catalysts

About Aehr Test Systems

Aehr Test Systems supplies wafer-level and package-level burn-in and test equipment used to screen and qualify semiconductors for reliability.

What are the underlying business or industry changes driving this perspective?

  • Rising AI processor and data center demand is feeding into Aehr Test Systems' FOX wafer-level and Sonoma package-level platforms. These platforms are tied to large purchase orders, a record backlog of about US$100.6 million, and a fiscal 2027 revenue outlook of US$130 million to US$150 million that directly targets higher revenue and operating income.
  • Growing adoption of optical I/O and silicon photonics in data centers is drawing repeat system orders and forecasts for additional FOX test cells. This can support a larger installed base of equipment and recurring WaferPak consumable sales that influence both revenue and gross margin mix.
  • Electrification in autos and rising power needs in AI data centers are supporting interest in silicon carbide and gallium nitride wafer-level burn-in. This includes recent WaferPak orders of about US$8 million and new GaN and silicon MOSFET applications, which expands the addressable market for systems and consumables and can affect long-term revenue growth.
  • Early work with NAND flash and high-bandwidth memory suppliers, along with engineering investment in memory-optimized Blades, positions Aehr Test Systems to participate if memory customers move to wafer-level burn-in. This would introduce a new revenue stream with potential impact on utilization and gross margin structure.
  • Expanded manufacturing capacity in Fremont and at a contract manufacturer in Southeast Asia, plus a larger presence in Taiwan, is designed to support higher volumes of FOX and Sonoma systems and consumables. This can help convert backlog into revenue more quickly and support the non-GAAP pretax margin target of 18% to 22%.
NasdaqCM:AEHR Earnings & Revenue Growth as at Aug 2026
NasdaqCM:AEHR Earnings & Revenue Growth as at Aug 2026

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Aehr Test Systems's revenue will grow by 75.6% annually over the next 3 years.
  • Analysts assume that profit margins will increase from -14.3% today to 30.8% in 3 years time.
  • Analysts expect earnings to reach $83.4 million (and earnings per share of $2.35) by about August 2029, up from -$7.1 million today.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 85.6x on those 2029 earnings, up from -613.7x today. This future PE is greater than the current PE for the US Semiconductor industry at 51.4x.
  • Analysts expect the number of shares outstanding to grow by 7.0% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 11.2%, as per the Simply Wall St company report.
NasdaqCM:AEHR Future EPS Growth as at Aug 2026
NasdaqCM:AEHR Future EPS Growth as at Aug 2026

Risks

What could happen that would invalidate this narrative?

  • Aehr Test Systems is heavily tied to AI processors and data center infrastructure, with AI related markets representing about 71% of fiscal 2026 revenue and silicon photonics and optical test a further 20%. Any slowdown or capex pause from these customers could reduce system orders and consumable pull through, which would directly affect revenue and earnings.
  • Customer concentration appears high, with a lead AI wafer-level burn-in customer doubling systems, a hyperscale customer issuing a record US$41 million Sonoma order, and three customers each contributing more than 10% of Q4 revenue. A single design loss, qualification delay or transition to an alternative solution could hit utilization, gross margin and net income.
  • The growth plan depends on converting a record backlog of about US$100.6 million and large new opportunities in AI, silicon photonics, GaN, silicon carbide and memory into sustained orders. Any qualification slip, technology change or slower than expected adoption of wafer-level burn in could limit how much of the guided US$130 million to US$150 million fiscal 2027 revenue range is achieved, affecting operating leverage and pretax margins.
  • Aehr Test Systems is investing ahead of demand with expanded Fremont capacity, outsourced Sonoma production in Southeast Asia that can support more than 20 systems per month, and a larger presence in Taiwan. If volumes or product mix fall short of current expectations, higher fixed costs, legal expenses from ongoing IP litigation and added headcount could pressure gross margin and net income.
  • The company is targeting new long-term markets such as GaN power devices and memory, including NAND flash and high bandwidth memory. Current guidance assumes minimal or no memory revenue and GaN volumes are not quantified, which means execution risk in these new segments could limit diversification benefits and keep revenue and earnings more sensitive to the AI and data center cycles.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of $130.0 for Aehr Test Systems based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $175.0, and the most bearish reporting a price target of just $110.0.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $270.6 million, earnings will come to $83.4 million, and it would be trading on a PE ratio of 85.6x, assuming you use a discount rate of 11.2%.
  • Given the current share price of $134.06, the analyst price target of $130.0 is 3.1% lower. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Aehr Test Systems?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Comments

0 comments

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

US$37.42
FV
116.0% overvalued intrinsic discount
26.99%
Revenue growth p.a.
328
users have viewed this narrative
2users have liked this narrative
1users have commented on this narrative
17users have followed this narrative

Fair Value vs Share Price

US$130
vs US$80.8137.8% undervalued intrinsic discount
PastFuture-8m271m2015201820212024202620272029Revenue US$270.6mEarnings US$83.4m
75.6%
Revenue growth
30.8%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Aehr Test Systems

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Flawless balance sheet with high growth potential.

Market capUS$3.0b
PB12.0x
Estimated Growth43.6%
Dividend YieldN/A
Full analysis

CEO & management

Gayn Erickson
CEO
3.8yrs
CEO Tenure

Provides test solutions for testing, burn-in, and semiconductor devices at wafer level, singulated die, and package level in the United States, Asia, Europe, and the Middle East.